156 related articles for article (PubMed ID: 23859240)
1. A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.
Chen R; Wang S; Poptani H; Melhem ER; Herskovits EH
Neuroradiol J; 2013 Apr; 26(2):175-83. PubMed ID: 23859240
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.
Wang S; Kim S; Chawla S; Wolf RL; Knipp DE; Vossough A; O'Rourke DM; Judy KD; Poptani H; Melhem ER
AJNR Am J Neuroradiol; 2011 Mar; 32(3):507-14. PubMed ID: 21330399
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
Bauer AH; Erly W; Moser FG; Maya M; Nael K
Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.
Wang S; Kim SJ; Poptani H; Woo JH; Mohan S; Jin R; Voluck MR; O'Rourke DM; Wolf RL; Melhem ER; Kim S
AJNR Am J Neuroradiol; 2014 May; 35(5):928-34. PubMed ID: 24503556
[TBL] [Abstract][Full Text] [Related]
8. Differentiating Glioblastomas from Solitary Brain Metastases Using Arterial Spin Labeling Perfusion- and Diffusion Tensor Imaging-Derived Metrics.
Abdel Razek AAK; Talaat M; El-Serougy L; Abdelsalam M; Gaballa G
World Neurosurg; 2019 Jul; 127():e593-e598. PubMed ID: 30928596
[TBL] [Abstract][Full Text] [Related]
9. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy.
Wang W; Steward CE; Desmond PM
AJNR Am J Neuroradiol; 2009 Jan; 30(1):203-8. PubMed ID: 18842762
[TBL] [Abstract][Full Text] [Related]
10. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Suh CH; Kim HS; Choi YJ; Kim N; Kim SJ
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2278-86. PubMed ID: 23828115
[TBL] [Abstract][Full Text] [Related]
12. Differentiation among Glioblastomas, Primary Cerebral Lymphomas, and Solitary Brain Metastases Using Diffusion-Weighted Imaging and Diffusion Tensor Imaging: A PRISMA-Compliant Meta-analysis.
Zhang P; Liu B
ACS Chem Neurosci; 2020 Feb; 11(3):477-483. PubMed ID: 31922391
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
14. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of brain abscesses from glioblastomas and metastatic brain tumors: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging before and after mathematic contrast leakage correction.
Toh CH; Wei KC; Chang CN; Ng SH; Wong HF; Lin CP
PLoS One; 2014; 9(10):e109172. PubMed ID: 25330386
[TBL] [Abstract][Full Text] [Related]
16. Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.
Samani ZR; Parker D; Wolf R; Hodges W; Brem S; Verma R
Sci Rep; 2021 Jul; 11(1):14469. PubMed ID: 34262079
[TBL] [Abstract][Full Text] [Related]
17. Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.
Tsolaki E; Svolos P; Kousi E; Kapsalaki E; Fountas K; Theodorou K; Tsougos I
Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):751-61. PubMed ID: 23334798
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models.
Mao J; Zeng W; Zhang Q; Yang Z; Yan X; Zhang H; Wang M; Yang G; Zhou M; Shen J
BMC Med Imaging; 2020 Nov; 20(1):124. PubMed ID: 33228564
[TBL] [Abstract][Full Text] [Related]
19. Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
Wang S; Martinez-Lage M; Sakai Y; Chawla S; Kim SG; Alonso-Basanta M; Lustig RA; Brem S; Mohan S; Wolf RL; Desai A; Poptani H
AJNR Am J Neuroradiol; 2016 Jan; 37(1):28-36. PubMed ID: 26450533
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
